Chairman Charles E. Grassley, right, and ranking member Sen. Ron Wyden are seen before a Senate Finance Committee on drug pricing in America on February 26, 2019. (Tom Williams/CQ Roll Call)
Both the House and the Senate have competing bills aimed at addressing the rising costs of prescription drugs, a legislative priority backed by President Donald Trump.
But what would these various proposals accomplish, and how likely is it they’ll be signed into law?
[jwp-video n=”1″]
Recent Stories
Capitol Lens | Jet setters
At the Races: Waiting on SCOTUS
Supreme Court sides with Monsanto over cancer warning
‘The Senate sucks’: Chambers clash over voter ID bill inaction
Supreme Court lets US end Haiti, Syria immigrant protections